Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic Mutations

(2014) X. Liu et al.   CLINICAL CHEMISTRY

Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization

(2014) H. Do et al.   CLINICAL CHEMISTRY

Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

(2013) T. Liu et al.   CLINICAL CANCER RESEARCH

TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type

(2013) Markus Rechsteiner et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Characterization of Squamous Cell Cancers of the Vulvar Anterior Fourchette by Human Papillomavirus, p16INK4a, and p53

(2013) Miriam Reuschenbach et al.   Journal of Lower Genital Tract Disease

Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes

(2013) Rajesh R. Singh et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement

(2013) Cheng-Han Lee et al.   MODERN PATHOLOGY

Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity

(2013) Austin M Dulak et al.   NATURE GENETICS

BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer

(2012) Rachel N. Grisham et al.   CANCER

Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations

(2012) S. M. Hunter et al.   CLINICAL CANCER RESEARCH

Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates

(2012) Ananta Gurung et al.   HISTOPATHOLOGY

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas

(2012) Michael S Anglesio et al.   JOURNAL OF PATHOLOGY

RNF43is a tumour suppressor gene mutated in mucinous tumours of the ovary

(2012) Georgina L Ryland et al.   JOURNAL OF PATHOLOGY

Comprehensive genomic characterization of squamous cell lung cancers

(2012)   NATURE

GNA11andN-RASmutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system

(2012) M. Gessi et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Targeting Src in Mucinous Ovarian Carcinoma

(2011) Koji Matsuo et al.   CLINICAL CANCER RESEARCH

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm

(2011) Robert J. Kurman et al.   HUMAN PATHOLOGY

Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience

(2010) J. Alexandre et al.   ANNALS OF ONCOLOGY

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

(2010) A. S. Green et al.   BLOOD

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer

(2010) Helen J. Mackay et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases

(2010) Ali Dastranj Tabrizi et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Calculator for ovarian carcinoma subtype prediction

(2010) Steve E Kalloger et al.   MODERN PATHOLOGY

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

(2010) S. A. Forbes et al.   NUCLEIC ACIDS RESEARCH

Distinction of Primary and Metastatic Mucinous Tumors Involving the Ovary: Analysis of Size and Laterality Data by Primary Site With Reevaluation of an Algorithm for Tumor Classification

(2009) Anna V. Yemelyanova et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

(2009) Jessica N McAlpine et al.   BMC CANCER

A Non-canonical MEK/ERK Signaling Pathway Regulates Autophagy via Regulating Beclin 1

(2009) Jianrong Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

(2008) Sandro Pignata et al.   BMC CANCER

Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors

(2008) M. S. Anglesio et al.   MOLECULAR CANCER RESEARCH